Objectives:

  1. Describe the antibody-based agents and cellular therapies approved for use in adult B-cell ALL
  2. Discuss their impact on management guidelines and on the role of hematopoietic cell transplantation
  3. Discuss the challenges to their use and opportunities for further research

and

  1. Discuss the pathophysiology and management of cardiac and gastrointestinal immune related adverse events (irAEs)
  2. Discuss steroid-sparing strategies for immune related adverse events
Session date: 
Monday, April 8, 2019 - 12:00pm to 1:00pm
Speaker Name: 
Amy Wang, MD, MPH and Sherin J. Rouhani, MD, PhD
Location: 
UCMC
5841 South Maryland Avenue, MC2115
MC2115 HemOnc Conference Room E-215
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.